Metabolic Therapy in Glioblastoma—Mapping the Evidence for Ketogenic Diet as an Adjunctive Strategy
Nutrients · 03.08.2026 · 18 (15) · 2498
DOI: 10.3390/nu18152498 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 03.08.2026. Verfasst von Dominika Wiśniewska und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Collegium Medicum, University of Rzeszów, 35-310 Rzeszow, Poland. Hauptthemen laut MEDLINE: Diet, Ketogenic, Glioblastoma, Brain Neoplasms. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Glioblastoma multiforme (GB) is an extremely aggressive tumor of the central nervous system, characterized by rapid growth, high invasiveness, and significant resistance to treatment. A growing body of data indicates that metabolic reprogramming of GB cells may be a therapeutic target, and that the ketogenic diet (KD)—by limiting glucose and inducing ketosis—may modulate tumor metabolism. The aim of this review was to provide a synthetic presentation of the current state of knowledge regarding the use of KD as an adjunctive therapy in the treatment of GB, with a particular focus on the mechanisms of action, safety, feasibility and results of clinical trials.
Methods
The review was conducted in accordance with the Joanna Briggs Institute methodology and the PRISMA-ScR guidelines. A systematic search of PubMed, Scopus, EBSCO, Web of Science, Google Scholar, and Cochrane Library (1–10 April 2026) included studies on the use of KD in patients with GB. Full-text observational studies, randomised trials and reviews were included in the analysis. Data extraction was carried out according to the Population–Concept–Context (PCC) model.
Results
Of the 26 publications identified, 12 met the inclusion criteria. Preclinical data consistently indicate that KD may reduce glycolysis, lower insulin and IGF-1 levels, increase oxidative stress in cancer cells, and modulate the inflammatory microenvironment. Clinical trials confirm the safety and feasibility of KD, as well as the ability to maintain stable ketosis. Preliminary data suggest potential metabolic benefits and improved quality of life, however, clinical efficacy remains inconclusive due to small trials, heterogeneous dietary protocols, and a lack of randomized trials. The variety of interventions used (classic KD; MCT-KD-Medium-chain triglyceride KD; KD-IF—KD and intermittent fasting) makes it difficult to compare the results.
Conclusions
The KD represents a promising, low-toxic strategy to support the treatment of GB, based on biological basis. Available data indicate its safety and feasibility, but there is insufficient evidence to recommend its routine use in clinical practice. Large, multicenter, randomized trials with standardized dietary protocols and objective monitoring of metabolic parameters are needed to unambiguously assess the impact of KD on disease survival and progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Collegium Medicum, University of Rzeszów, 35-310 Rzeszow, Poland.
- Department of Surgery, Faculty of Medicine, Collegium Medicum, University of Rzeszów, 35-310 Rzeszow, Poland.
ORCID-Profile: Dominika Wiśniewska, Martyna Winiarska, Sabina Krupa-Nurcek
Zitieren
APA
Wiśniewska, D., Winiarska, M., & Krupa-Nurcek, S. (2026). Metabolic Therapy in Glioblastoma—Mapping the Evidence for Ketogenic Diet as an Adjunctive Strategy. Nutrients, 18(15), 2498. https://doi.org/10.3390/nu18152498
Vancouver
Wiśniewska D, Winiarska M, Krupa-Nurcek S. Metabolic Therapy in Glioblastoma—Mapping the Evidence for Ketogenic Diet as an Adjunctive Strategy. Nutrients. 2026;18(15):2498. doi:10.3390/nu18152498
BibTeX
@article{Winiewska2026,
author = {Wiśniewska, Dominika and Winiarska, Martyna and Krupa-Nurcek, Sabina},
title = {Metabolic Therapy in Glioblastoma—Mapping the Evidence for Ketogenic Diet as an Adjunctive Strategy},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {15},
pages = {2498},
doi = {10.3390/nu18152498}
}
EUVIMED